Hillcrest Hospice 1820 Hillcrest Drive, Suite B, Bellevue, NE, 68005 | |
(402) 934-2282 |
News Archive
Scient'x Groupe S.A.S. (Scient'x) announces its focus on offering Dynamic Solutions for the spine. This corporate strategy positions Scient'x to be the worldwide leader in providing Dynamic Solutions for both non-fusion and fusion procedures.
An experimental drug has shown promise in treating influenza, preventing lung injury and death from the virus in preclinical studies, according to University of Maryland School of Medicine researchers publishing in the journal Nature on May 1.
The National Community Pharmacists Association (NCPA) commended the Senate for passing a bill extending from Sept. 30 to Dec. 31, 2009 the deadline for meeting pharmacy accreditation requirements to continue offering Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).
The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.
› Verified 7 days ago
Name | Hillcrest Hospice |
---|---|
Location | 1820 Hillcrest Drive, Suite B, Bellevue, Nebraska |
Hospice ID | 281545 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | Accreditation Commission for Health Care (ACHC) |
SSA county code | 760 |
News Archive
Scient'x Groupe S.A.S. (Scient'x) announces its focus on offering Dynamic Solutions for the spine. This corporate strategy positions Scient'x to be the worldwide leader in providing Dynamic Solutions for both non-fusion and fusion procedures.
An experimental drug has shown promise in treating influenza, preventing lung injury and death from the virus in preclinical studies, according to University of Maryland School of Medicine researchers publishing in the journal Nature on May 1.
The National Community Pharmacists Association (NCPA) commended the Senate for passing a bill extending from Sept. 30 to Dec. 31, 2009 the deadline for meeting pharmacy accreditation requirements to continue offering Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).
The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.
› Verified 7 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.7 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 95.2 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 86.5 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
Patients who got timely treatment for shortness of breath | 96.4 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 96.5 | 93.3 |
News Archive
Scient'x Groupe S.A.S. (Scient'x) announces its focus on offering Dynamic Solutions for the spine. This corporate strategy positions Scient'x to be the worldwide leader in providing Dynamic Solutions for both non-fusion and fusion procedures.
An experimental drug has shown promise in treating influenza, preventing lung injury and death from the virus in preclinical studies, according to University of Maryland School of Medicine researchers publishing in the journal Nature on May 1.
The National Community Pharmacists Association (NCPA) commended the Senate for passing a bill extending from Sept. 30 to Dec. 31, 2009 the deadline for meeting pharmacy accreditation requirements to continue offering Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).
The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.
› Verified 7 days ago
Home Health Aides | 3.5 |
Counselors | 1.25 |
Licensed Practical or Vocational Nurses | 0.25 |
Medical Social Workers | 2 |
Registered Nurses | 7 |
Other Personnel | 4.75 |
Total Employees | 18.75 |
---|
News Archive
Scient'x Groupe S.A.S. (Scient'x) announces its focus on offering Dynamic Solutions for the spine. This corporate strategy positions Scient'x to be the worldwide leader in providing Dynamic Solutions for both non-fusion and fusion procedures.
An experimental drug has shown promise in treating influenza, preventing lung injury and death from the virus in preclinical studies, according to University of Maryland School of Medicine researchers publishing in the journal Nature on May 1.
The National Community Pharmacists Association (NCPA) commended the Senate for passing a bill extending from Sept. 30 to Dec. 31, 2009 the deadline for meeting pharmacy accreditation requirements to continue offering Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).
The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.
› Verified 7 days ago
Homemakers | 0.25 |
Others | 0.75 |
Total Volunteers | 1 |
---|
News Archive
Scient'x Groupe S.A.S. (Scient'x) announces its focus on offering Dynamic Solutions for the spine. This corporate strategy positions Scient'x to be the worldwide leader in providing Dynamic Solutions for both non-fusion and fusion procedures.
An experimental drug has shown promise in treating influenza, preventing lung injury and death from the virus in preclinical studies, according to University of Maryland School of Medicine researchers publishing in the journal Nature on May 1.
The National Community Pharmacists Association (NCPA) commended the Senate for passing a bill extending from Sept. 30 to Dec. 31, 2009 the deadline for meeting pharmacy accreditation requirements to continue offering Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).
The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.
› Verified 7 days ago
Hillcrest Hospice Location: 1820 Hillcrest Drive, Suite B, Bellevue, Nebraska, 68005 Phone: (402) 934-2282 |